Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 9,920 shares at $110.82 ($1.1M) on 2022-10-17, disclosed to the SEC on 2022-10-19.
Open-market sale of $1.1M NBIX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.82 | 4,960 | $550K | 50.0% |
| 2 | $110.82 | 4,960 | $550K | 50.0% |
| Total | $110.82 avg | 9,920 | $1.1M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |